942 related articles for article (PubMed ID: 17674186)
1. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Sukhodolsky DG; Scahill L; Gadow KD; Arnold LE; Aman MG; McDougle CJ; McCracken JT; Tierney E; Williams White S; Lecavalier L; Vitiello B
J Abnorm Child Psychol; 2008 Jan; 36(1):117-28. PubMed ID: 17674186
[TBL] [Abstract][Full Text] [Related]
2. Attention deficit/hyperactivity disorder symptoms moderate cognition and behavior in children with autism spectrum disorders.
Yerys BE; Wallace GL; Sokoloff JL; Shook DA; James JD; Kenworthy L
Autism Res; 2009 Dec; 2(6):322-33. PubMed ID: 19998356
[TBL] [Abstract][Full Text] [Related]
3. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study.
Di Martino A; Melis G; Cianchetti C; Zuddas A
J Child Adolesc Psychopharmacol; 2004; 14(2):207-18. PubMed ID: 15319018
[TBL] [Abstract][Full Text] [Related]
5. Attention deficit hyperactivity disorder symptoms in pervasive developmental disorders: association with autistic behavior domains and coexisting psychopathology.
Holtmann M; Bolte S; Poustka F
Psychopathology; 2007; 40(3):172-7. PubMed ID: 17318010
[TBL] [Abstract][Full Text] [Related]
6. Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response.
Arnold LE; Gadow KD; Farmer CA; Findling RL; Bukstein O; Molina BS; Brown NV; Li X; Rundberg-Rivera EV; Bangalore S; Buchan-Page K; Hurt EA; Rice R; McNamara NK; Aman MG
J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):203-12. PubMed ID: 25885010
[TBL] [Abstract][Full Text] [Related]
7. Attention deficit/hyperactivity disorder in children and adolescents with autism spectrum disorder: symptom or syndrome?
Sinzig J; Walter D; Doepfner M
J Atten Disord; 2009 Sep; 13(2):117-26. PubMed ID: 19380514
[TBL] [Abstract][Full Text] [Related]
8. The presentation of anxiety in children with pervasive developmental disorders.
Weisbrot DM; Gadow KD; DeVincent CJ; Pomeroy J
J Child Adolesc Psychopharmacol; 2005 Jun; 15(3):477-96. PubMed ID: 16092912
[TBL] [Abstract][Full Text] [Related]
9. Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.
Posey DJ; Wiegand RE; Wilkerson J; Maynard M; Stigler KA; McDougle CJ
J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):599-610. PubMed ID: 17069548
[TBL] [Abstract][Full Text] [Related]
10. Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity.
Jahromi LB; Kasari CL; McCracken JT; Lee LS; Aman MG; McDougle CJ; Scahill L; Tierney E; Arnold LE; Vitiello B; Ritz L; Witwer A; Kustan E; Ghuman J; Posey DJ
J Autism Dev Disord; 2009 Mar; 39(3):395-404. PubMed ID: 18752063
[TBL] [Abstract][Full Text] [Related]
11. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders.
Scahill L; McDougle CJ; Williams SK; Dimitropoulos A; Aman MG; McCracken JT; Tierney E; Arnold LE; Cronin P; Grados M; Ghuman J; Koenig K; Lam KS; McGough J; Posey DJ; Ritz L; Swiezy NB; Vitiello B;
J Am Acad Child Adolesc Psychiatry; 2006 Sep; 45(9):1114-23. PubMed ID: 16926619
[TBL] [Abstract][Full Text] [Related]
12. Methylphenidate an effective treatment for ADHD?
McDougle CJ
J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613
[No Abstract] [Full Text] [Related]
13. Reliability and validity of the Pervasive Developmental Disorders Assessment System.
Kurita H; Koyama T; Inoue K
Psychiatry Clin Neurosci; 2008 Apr; 62(2):226-33. PubMed ID: 18412847
[TBL] [Abstract][Full Text] [Related]
14. [Anxiety in children and adolescents with pervasive developmental disorder without mental retardation: review of literature].
Soussana M; Sunyer B; Pry R; Baghdadli A
Encephale; 2012 Feb; 38(1):16-24. PubMed ID: 22381719
[TBL] [Abstract][Full Text] [Related]
15. [Cognitive profiles in pervasive developmental disorders].
Girardot AM; De Martino S; Chatel C; Da Fonseca D; Rey V; Poinso F
Encephale; 2012 Dec; 38(6):488-95. PubMed ID: 23200615
[TBL] [Abstract][Full Text] [Related]
16. Predicting children with pervasive developmental disorders using the Wechsler Intelligence Scale for Children-Third Edition.
Koyama T; Inada N; Tsujii H; Kurita H
Psychiatry Clin Neurosci; 2008 Aug; 62(4):476-8. PubMed ID: 18778447
[TBL] [Abstract][Full Text] [Related]
17. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
[TBL] [Abstract][Full Text] [Related]
18. Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.
Scahill L; McDougle CJ; Aman MG; Johnson C; Handen B; Bearss K; Dziura J; Butter E; Swiezy NG; Arnold LE; Stigler KA; Sukhodolsky DD; Lecavalier L; Pozdol SL; Nikolov R; Hollway JA; Korzekwa P; Gavaletz A; Kohn AE; Koenig K; Grinnon S; Mulick JA; Yu S; Vitiello B;
J Am Acad Child Adolesc Psychiatry; 2012 Feb; 51(2):136-46. PubMed ID: 22265360
[TBL] [Abstract][Full Text] [Related]
19. A prospective open trial of guanfacine in children with pervasive developmental disorders.
Scahill L; Aman MG; McDougle CJ; McCracken JT; Tierney E; Dziura J; Arnold LE; Posey D; Young C; Shah B; Ghuman J; Ritz L; Vitiello B
J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):589-98. PubMed ID: 17069547
[TBL] [Abstract][Full Text] [Related]
20. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
